Heska Corp.

Formerly NASDAQ: HSKA
8 Heska Corp. Expert Interviews, now on BamSEC.
 Powered by Tegus.

Material Contracts Filter

EX-10.31
from 10-K 13 pages Employment Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Amendment to Heska Corporation Equity Incentive Plan
12/34/56
EX-10.2
from 10-Q 14 pages Heska Corporation Equity Incentive Plan Effective May 5, 2021 Article 1. Introduction
12/34/56
EX-10.1
from 8-K 44 pages Amended and Restated Employment Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Fourth Amendment to Clinical Chemistry Analyzer Agreement
12/34/56
EX-10.32
from 10-K 14 pages Employment Agreement
12/34/56
EX-10.31
from 10-K 14 pages Employment Agreement
12/34/56
EX-10.30
from 10-K 9 pages 1.effective Date. This Agreement Shall Become Effective on the Eighth Day After Employee Signs This Agreement (The "Effective Date"), So Long as Employee Does Not Revoke This Agreement Pursuant to Paragraph 10 Below. Employee's Termination Date Will Not Change Regardless of Whether This Agreement Becomes Effective on the "Effective Date." 2. Consideration for Release and Payment Terms
12/34/56
EX-10.15
from 10-K 4 pages Heska Corporation Management Incentive Plan Master Document Amended and Restated as of February 17, 2021
12/34/56
EX-10.1
from 10-Q 20 pages Amendment No. 7 to the Supply and License Agreement by and Between Heska Corporation and Intervet Inc., D/B/a Merck Animal Health
12/34/56
EX-10.3
from 10-Q 14 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 24 pages Amended and Restated Supply Agreement
12/34/56
EX-10.1
from 10-Q 5 pages First Amendment to Exclusive Supply Agreement
12/34/56
EX-10.2
from 10-Q 22 pages Heska Corporation Stock Incentive Plan Most Recently Amended and Restated Effective April 8, 2020 1 Heska Corporation Stock Incentive Plan Most Recently Amended and Restated Effective April 8, 2020
12/34/56
EX-10.1
from 10-Q 10 pages Heska Corporation 2020 Employee Stock Purchase Plan
12/34/56
EX-10.2
from 8-K 23 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 9 pages Amendment to the Securities Purchase Agreement
12/34/56
EX-10.68
from 10-K 32 pages Securities Purchase Agreement
12/34/56
EX-10.57
from 10-K ~10 pages Third Amendment to Clinical Chemistry Analyzer Agreement
12/34/56
EX-10.39
from 10-K 9 pages Separation and Release Agreement
12/34/56